Ventura M T, Cannone A, Sinesi D, Buquicchio R, Carbonara M, Di Leo E, Bonini M, Dagnello M, Bonini S
Department of Internal Medicine, Immunology and Infectious Diseases, University of Bari Medical School, Policlinico, Italy.
Allergy. 2009 Apr;64(4):556-9. doi: 10.1111/j.1398-9995.2008.01857.x. Epub 2009 Jan 27.
The aim of this study was to identify the prevalence of allergic disease in young soccer players compared to age-matched students and to evaluate if this prevalence changes as the intensity of training increases.
A modified ECRHS questionnaire was administered to 194 soccer players divided by age as Beginners (8-11 years), Juniors (12-16 years) and Under 21 (17-20 years) to evaluate the prevalence of allergic diseases and symptoms as well as drug consumption. Subjects with a positive personal history of allergic diseases underwent skin prick and/or patch tests. Age-matched students (n = 136) were used as a control group.
The prevalence of allergic diseases was 34.5% in soccer players and 31.6% in control subjects (n.s.). Skin sensitization to inhalant allergens was detected in 14.4% of symptomatic soccer players and in 19.2% of control students (n.s.). Patch tests were positive in 35.7% of soccer players and 23.0% of controls with allergic dermatitis (n.s.). The prevalence of allergic diseases did not significantly change in relation to the intensity of training. Although the relative prevalence of sensitization to perennial allergens and asthma was less frequent in soccer players than in controls, and the occurrence of exercise-induced bronchoconstriction was similar in the two groups, soccer players used twice as many anti-allergic and anti-asthmatic drugs as control students.
An increasingly intensive training programme is not associated with greater risk of allergic disease in soccer players. Therapy regimens of allergic athletes and exercisers should be monitored more closely to guarantee adequate treatment yet avoid inappropriate drug use and doping practices.
本研究的目的是确定年轻足球运动员与年龄匹配的学生相比过敏性疾病的患病率,并评估随着训练强度增加这种患病率是否会发生变化。
对194名足球运动员采用改良的欧洲社区呼吸健康调查(ECRHS)问卷进行调查,这些运动员按年龄分为初学者(8 - 11岁)、青少年(12 - 16岁)和21岁以下(17 - 20岁),以评估过敏性疾病和症状的患病率以及药物使用情况。有过敏性疾病个人史阳性的受试者接受皮肤点刺和/或斑贴试验。年龄匹配的学生(n = 136)作为对照组。
足球运动员中过敏性疾病的患病率为34.5%,对照组为31.6%(无统计学差异)。在有症状的足球运动员中,14.4%检测到对吸入性过敏原的皮肤致敏,对照组学生中为19.2%(无统计学差异)。在患有过敏性皮炎的足球运动员中,35.7%斑贴试验呈阳性,对照组为23.0%(无统计学差异)。过敏性疾病的患病率与训练强度无显著变化。尽管足球运动员对常年性过敏原致敏和哮喘的相对患病率低于对照组,且两组运动诱发支气管收缩的发生率相似,但足球运动员使用的抗过敏和抗哮喘药物是对照学生的两倍。
足球运动员训练计划强度增加与过敏性疾病风险增加无关。应更密切地监测过敏性运动员和运动者的治疗方案,以确保充分治疗,同时避免不当用药和兴奋剂行为。